Bliss GVS Pharma rose 2.33% to Rs 182 at 14:00 IST on BSE after consolidated net profit spurted 108.5% to Rs 36.87 crore on 79.9% increase in net sales to Rs 258.30 crore in Q4 March 2017 over Q4 March 2016.
The result was announced after market hours yesterday, 16 May 2017.
High volumes were witnessed on the counter. On the BSE, 3.57 lakh shares were traded on the counter so far as against the average daily volumes of 79,604 shares in the past one quarter.
The stock had hit a high of Rs 185.50 and a low of Rs 180.80 so far during the day.
The stock had hit a 52-week high of Rs 187.75 on 28 March 2017 and a 52-week low of Rs 79 on 17 June 2016. The stock had underperformed the market over the past one month till 16 May 2017, advancing 3.1% compared with the Sensex's 3.81% rise. The scrip had, however, outperformed the market over the past one quarter advancing 18.37% as against the Sensex's 8.06% rise.
The small-cap company has equity capital of Rs 10.31 crore. Face value per share is Rs 1.
Bliss GVS Pharma is engaged in developing, manufacturing and marketing pharmaceutical formulations.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)